Electronic screening for mental illness in patients with psoriasis
Open Access
- 24 May 2023
- journal article
- letter
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 189 (2) , 246-248
Abstract
In this cross-sectional study from a large UK centre, screening for mental illness in individuals with psoriasis has demonstrated a high burden of depression and anxiety. Overall, 85% of the cohort reported that their psoriasis had affected their quality of life. Quality-of-life scores correlate with depression scores, emphasizing the importance of managing the individual’s mental health alongside their psoriasis to improve overall quality of life.Keywords
Funding Information
- National Institute for Health and Care Research
- NIHR Research for Patient Benefit programme
- Department of Health and Social Care
- Wellcome Trust Senior Research Fellowship in Clinical Science (205039/Z/16/Z)
- European Union Horizon 2020-funded BIOMAP Consortium
- Wellcome Trust (G205039/Z/16/Z)
This publication has 7 references indexed in Scilit:
- Factors associated with depression, anxiety and severe mental illness among adults with atopic eczema or psoriasis: a systematic review and meta-analysisBritish Journal of Dermatology, 2022
- Screening for depression in psoriasis patients during a dermatological consultation: A first step towards treatmentJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2021
- Risk of first‐time and recurrent depression in patients with psoriasis: a population‐based cohort studyBritish Journal of Dermatology, 2018
- Screening for anxiety and depression in people with psoriasis: a cross-sectional study in a tertiary referral settingBritish Journal of Dermatology, 2016
- A Brief Measure for Assessing Generalized Anxiety DisorderArchives of internal medicine (1960), 2006
- The PHQ-9Journal of General Internal Medicine, 2001
- Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical useClinical and Experimental Dermatology, 1994